Eicosanoids and resistance of cancer cells to chemotherapeutic agents
A Sorokin - Sensitization of Cancer Cells for Chemo/Immuno/Radio …, 2008 - Springer
Apoptosis, or programmed cell death, is a normal physiologic process of cell deletion in
embryonic development as well as in the maintenance of tissue and organ homeostasis …
embryonic development as well as in the maintenance of tissue and organ homeostasis …
Cyclooxygenase-2 contributes to mutant epidermal growth factor receptor lung tumorigenesis by promoting an immunosuppressive environment.
M Kim, A Iravani, M Topham - Cancer Translational Medicine, 2020 - go.gale.com
Targeted therapies reduce growth of mutant epidermal growth factor receptor (EGFR) non-
small cell lung cancers, but most patients develop drug resistance. This has led to efforts to …
small cell lung cancers, but most patients develop drug resistance. This has led to efforts to …
Mechanisms of tumor cell migration and invasion in lung cancer metastasis
CK Thodeti, K Ghosh - … : Novel Biological Mechanisms and Impact on …, 2010 - Springer
Cancer metastasis is a multistep process that involves tumor cell migration and invasion
through tumor stroma, intravasation into and extravasation out of the blood vessels, and …
through tumor stroma, intravasation into and extravasation out of the blood vessels, and …
Investigation of the mechanisms and therapeutic implications of crosstalk between G-protein-coupled receptors and the Epidermal Growth Factor Receptor in HNSCC
N Bhola - 2009 - search.proquest.com
Head and neck squamous cell carcinoma (HNSCC) is characterized by the overexpression
of the epidermal growth factor receptor. However, molecular targeting strategies against …
of the epidermal growth factor receptor. However, molecular targeting strategies against …
[PDF][PDF] ACTIVITY OF TG01, A SELECTIVE COX-2 INHIBITOR, ALONE AND IN COMBINATION WITH DOCETAXEL IN HUMAN NON-SMALL CELL LUNG CARCINOMA …
TL Lawhon, SL Zaknoen, AJ Wong, KR Meshaw… - 2008 - Citeseer
The cyclooxygenase (COX) pathway has been implicated in carcinogenesis since the 1970s
when increased concentrations of prostaglandins were detected in neoplastic tissues …
when increased concentrations of prostaglandins were detected in neoplastic tissues …
Impact du célécoxib sur l'inflammation pendant les chirurgies du cancer: une étude clinique randomisée
JG Hiller, S Sampurno, R Millen, N Kuruvilla… - Canadian Journal of …, 2017 - Springer
Résumé Objectif Pendant les chirurgies du cancer, l'inflammation médiée par les
prostaglandines pourrait favoriser et activer une maladie micrométastatique avec une …
prostaglandines pourrait favoriser et activer une maladie micrométastatique avec une …
[PDF][PDF] Severe gastrointestinal bleeding due to erlotinib and celecoxib therapy: additional effect?
M Zippi, A De Quarto, C Marzano, C Cassieri… - Italian Journal of …, 2017 - italjmed.org
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related dead worldwide
and accounts for over 85% of all lung cancers. Furthermore, the majority of patients with …
and accounts for over 85% of all lung cancers. Furthermore, the majority of patients with …
[PDF][PDF] Synteza i właściwości nowych pochodnych 1, 2-benzotiazyny jako potencjalnych leków wielocelowych o działaniu chemoprewencyjnym i przeciwbólowym
B Szczęśniak-Sięga - 2016 - scholar.archive.org
Pomimo intensywnych wysiłków i znacznych postępów poczynionych w dziedzinie leczenia
chorób nowotworowych, rak, obok chorób układu krążenia, jest nadal najistotniejszą …
chorób nowotworowych, rak, obok chorób układu krążenia, jest nadal najistotniejszą …
افزایش حساسیت تومور به اشعه با استفاده از سلکوکسیب
جلال آبادی, شیرازی, قوام نصیری, آل داوود… - مجله دانشگاه علوم …, 2016 - jsums.medsab.ac.ir
زمینه و هدف: سرطان یکی از مهمترین عوامل مرگومیر در دنیا میباشد. به دلیل پیشرفتهای قابل توجه
در علم زیستشناسی مولکولی و سلولی، روشهای قبلی درمان سرطان با استراتژیهای جدید بهبود …
در علم زیستشناسی مولکولی و سلولی، روشهای قبلی درمان سرطان با استراتژیهای جدید بهبود …
[PDF][PDF] Celecoxib and Mucosal Protection: Translation from an Animal Model to a Phase I Clinical Trial of Celecoxib, Irinotecan, and 5-Fluorouracil
PF Smith, PJ Creaven, DC Noel, RV Iyer, YM Rustum - researchgate.net
Purpose: Chemotherapy-induced diarrhea occurs secondary to mucosal inflammation and
may be cyclooxygenase-2 mediated. Cyclooxygenase-2 inhibitors may ameliorate …
may be cyclooxygenase-2 mediated. Cyclooxygenase-2 inhibitors may ameliorate …